As shown in Figure 6A, verteporfin indeed reduces phosphorylation of YAP1 in PC9 lung cancer cells at baseline or in the presence of cisplatin, whereas a YES inhibitor, dasatinib had no such effects. Here, YAP1 is linked to lung cancer.